Piramal Pharma Ltd. expects new molecule development and an $80 million expansion of its sterile injectable facility in ...

Asia, with 8% from Europe, the Middle East, and Africa. 95% of the funds came from asset managers, while 5% were raised from ...

Piramal Capital & Housing Finance Limited (Piramal Finance), a wholly-owned subsidiary of Piramal Enterprises Ltd (PEL), to ...

Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635) has released its third independent annual Sustainability Report ...

Piramal Pharma Solutions, a contract development and manufacturing organisation, has announced an $80m investment to expand ...

Piramal Capital and Housing Finance raises USD 150 million through a global bond sale, achieving a better pricing than ...

Piramal Finance raises $150 million from international markets at 7.078% yield, attracting high-quality demand from global ...

From a geographical spread perspective, 92 per cent of the funds were raised from Asia, while the rest was from Europe, ...

It’s like a series of dominoes falling one after another, which usually signals contagion or some risk spread across the ...

Piramal Pharma Solutions invests $80 million in Lexington facility expansion to meet growing demand in injectables market.

Piramal Pharma plans to double its turnover to $2 billion by 2030, focusing on its CDMO business and high-growth sectors like ...